Medicine: Study finds Racial Disparity in Pro-Metastatic Tumor Microenvironment Among Women with Residual Breast Cancer after neoadjuvant chemotherapy
Bronx, NY, December 08, 2022.- Residual tumors from Black patients with estrogen receptor (ER)-positive/HER2- negative primary breast cancer treated with neoadjuvant chemotherapy (NAC) had a higher score of a biomarker of distant metastatic recurrence than tumors from white patients, according to data presented at the San Antonio Breast Cancer Symposium,Continuar Leyendo


















